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Abstract
Purpose Severe fluctuations in plasma sodium concentration and plasma osmolarity, including central diabetes insipidus 
(CDI), may have significant influence on postoperative morbidity and mortality after pediatric brain tumor surgery.The aim 
of this study was to describe the frequency, severity and neurological consequences of these fluctuations in pediatric brain 
tumor survivors.
Methods A retrospective, multi-institutional chart review was conducted among all children who underwent brain tumor 
surgery in the sellar or suprasellar region in seven university hospitals in the Netherlands between January 2004 and Decem-
ber 2013.
Results Postoperative CDI was observed in 67.5% of 120 included children. Fluctuations of plasma sodium concentra-
tion ≥ 10 mmol/L/24 h during the first ten postoperative days were seen in 75.3% of patients with CDI, with a maximum delta 
of 46 mmol/L/24 h. When compared to patients without CDI, altered mental status occurred more frequently in patients with 
postoperative CDI (5.1 vs. 23.5% respectively, p = 0.009). Low plasma sodium concentration was related to altered mental 
status and the occurrence of seizures. Frequency and severity of fluctuations in plasma sodium concentration during the 
first ten postoperative days were significantly higher in patients with permanent CDI at last follow-up than in patients with 
transient CDI or without CDI (p = 0.007).
Conclusion Postoperative CDI is a common complication after pediatric brain tumor surgery in the sellar or suprasellar 
region. Extreme plasma sodium concentrations and large intra-day fluctuations still occur and seem to influence the postop-
erative neurological course. These results illustrate the need for intensive monitoring in a highly experienced center.
Keywords Child · Plasma sodium concentration · Diabetes insipidus · Brain neoplasm · Neurological effect · Neurological 
consequence
Introduction
Tumors in the sellar or suprasellar region account for 
approximately 10% of all pediatric brain tumors [1]. Crani-
opharyngiomas account for the majority of sellar tumors in 
children, representing 1.2–4% of all pediatric intracranial 
tumors [2, 3]. Although central diabetes insipidus (CDI) 
can be the presenting symptom of sellar tumors, most often 
it occurs as a complication of the surgical treatment, with 
incidences ranging from 10 to 60% [4–6]. Patients with post-
operative CDI have a transient or permanent lack of antidiu-
retic hormone (ADH), caused by perioperative manipula-
tion or damage to the neurohypophyseal system. CDI in the 
postoperative period may present with a triphasic response 
in the sodium and fluid balance [CDI, followed by the syn-
drome of inappropriate ADH secretion (SIADH), followed 
again by CDI]. This triphasic response may be explained 
by an axonic shock and instability of the posterior pituitary 
to secrete ADH, followed by leakage of ADH from the dis-
torted neurons. Exhaustion of all ADH results in permanent 
CDI [7]. During the first hours postoperatively, it may be 
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difficult to distinguish between CDI and polyuria caused by 
perioperative administration of large volumes of fluids. In 
the second phase of the triphasic response with oliguria and 
hyponatremia, it can be challenging to differentiate inappro-
priate secretion of ADH (endogenous or exogenous) from 
cerebral salt wasting or the administration of hypotonic flu-
ids. The occurrence of postoperative CDI, with or without 
the triphasic response, may lead to significant fluctuations 
in plasma sodium concentration. Abnormal or steep changes 
in plasma sodium concentration may have significant influ-
ence on postoperative morbidity and mortality [8–10]. Steep 
decline in plasma sodium concentration (hyponatremia) 
is known to cause seizures, encephalopathy, and cerebral 
edema, which are potential sources of secondary brain injury 
among neurosurgical patients [8]. Severe hypernatremia 
occurs when fluid replacement is insufficient to compensate 
for the water loss and/or exogenous sodium substitution. 
Neurosurgical pediatric patients may have altered or absent 
awareness of thirst in the direct postoperative period, which 
makes them vulnerable to developing severe hypernatremia 
[9]. Acquired hypernatremia appears to signal higher risk 
of mortality in children with severe traumatic brain injury 
and has been associated with a higher level of care needed 
by survivors of severe traumatic brain injury at the time of 
discharge [10]. For these reasons, it is important to moni-
tor the sodium and fluid balance closely in patients who 
underwent tumor surgery in the sellar region. The primary 
aim of our study was to evaluate the frequency, severity and 
neurological consequences of postoperative fluctuations in 
plasma sodium concentration in children with (supra)sellar 
lesions. Secondary, we aimed to disclose the risk factors for 
developing severe fluctuations in plasma sodium concentra-
tion in the early postoperative period (within 10 days after 
surgery).
Patients and methods
Population
A national retrospective cohort was selected from all chil-
dren diagnosed with a sellar or suprasellar tumor who under-
went neurosurgery in the Netherlands between January 2004 
and December 2013. Patients were recruited from the seven 
university hospitals in the Netherlands that offered treat-
ment to children diagnosed with such a tumor. Patients were 
identified using patient registrations from the departments 
of Pediatric Neurosurgery, Pediatric Oncology or Pediatric 
Endocrinology. The lists with selected patients were hand-
searched by RK together with the local physician to check 
whether the reported diagnosis and inclusion was correct. 
Inclusion criteria for this study were (1) diagnosis of a 
sellar or suprasellar tumor; (2) initial surgery (transcranial 
or transsphenoidal approach) for tumor resection (gross 
total or partial resection) or biopsy; (3) age of 18 years or 
younger at the time of surgical intervention; (4) initial sur-
gery performed in the period from January 2004 to Decem-
ber 2013. Patients were excluded if data on plasma sodium 
concentration during the first ten postoperative days were 
not available or if the information from their medical charts 
was insufficient to determine whether they had experienced 
postoperative CDI or not. The study was approved by the 
Medical Ethical Committee of the Wilhelmina Children’s 
Hospital, Utrecht UMCU, The Netherlands. All collected 
data were anonymized. Based on these criteria, 130 chil-
dren were eligible for inclusion. Ten children were excluded 
from further analysis, because postoperative data on plasma 
sodium concentration or fluid balance were lacking. In total, 
120 patients (70 female and 50 male) were analyzed.
Data collection
Data at initial tumor surgery were gathered on gender, age, 
presenting symptoms and findings [seizures, visual impair-
ment, obesity, growth retardation, motor deficit, pre-opera-
tive CDI or (pan)hypopituitarism], duration of the presenting 
symptom at the time of diagnosis, tumor type, surgical data 
(type of surgery, surgical approach), plasma sodium con-
centration during the first ten postoperative days (highest 
and lowest plasma sodium concentration per day, highest 
and lowest plasma sodium concentration during the first ten 
postoperative days, delta plasma sodium concentration per 
24 h, largest delta plasma sodium concentration per 24 h, 
total amount of fluctuations in plasma sodium concentra-
tion ≥ 10 mmol/L/24 h), postoperative course [occurrence 
of CDI, transient or permanent CDI, occurrence of hypona-
tremia, occurrence of the triphasic response, administra-
tion of desmopressin pre- and post-operative, length of stay 
at the intensive care unit (ICU)], short-term neurological 
consequences possibly related to fluctuations in plasma 
sodium concentration (epileptic seizures, altered mental 
status), short-term complications probably not related to 
fluctuations in plasma sodium concentration, total number 
of resections per patient, adjuvant treatment (radiotherapy, 
chemotherapy), age at last follow-up, duration of follow-up, 
long-term neurological consequences (headache, seizures, 
visual impairment, motor deficit, cognitive dysfunction, 
sleeping problems, tiredness), long-term endocrine disor-
ders [prevalence of permanent CDI, (pan)hypopituitarism, 
obesity] and mortality were collected.
Definitions
CDI was defined as documented polyuria in combination 
with high plasma sodium concentration (> 145 mmol/L) or 
documentation of the diagnosis CDI in the medical chart. 
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CDI was classified as transient when patients did not require 
treatment with desmopressin anymore at time of hospital 
discharge. Early postoperative CDI was defined as the occur-
rence of CDI within ten postoperative days, late postopera-
tive CDI was defined as the presence of permanent CDI 
at last moment of follow-up. Syndrome of inappropriate 
ADH secretion (SIADH) was defined as documented oligu-
ria in combination with low plasma sodium concentration 
(< 135 mmol/L). The triphasic response was specified as the 
period of CDI in the early postoperative period preceded by 
a hyponatremic phase again preceded by a phase of polyuria. 
Short-term neurological consequences possibly related to 
fluctuations in plasma sodium concentration were defined 
as the presence of epileptic seizures or altered mental sta-
tus (Glasgow Coma Scale score < 15 or sleepiness/reduced 
alertness described in the clinical records) during the first 
ten postoperative days. Relevant postoperative complications 
probably occurring independent of fluctuations in plasma 
sodium concentration were defined as the presence of infec-
tions (meningitis, drain infection, central venous catheter 
infection, septicemia, pneumonia, erysipelas, cellulitis, 
fever of unknown origin treated with antibiotics), anemia 
requiring (multiple) blood transfusions or hyperglycaemia 
requiring insulin therapy. Long-term neurological conse-
quences were defined as headache, epileptic seizures (recent 
seizure or patient using anti-epileptic medication), visual 
impairment, motor deficit (decreased motor skills or muscle 
strength objectified by neurological examination), cognitive 
dysfunction, sleeping problems or fatigue (as reported in 
the medical chart) at the last moment of follow-up. Cogni-
tive deficits as poor concentration, memory problems and 
reduced processing speed were extracted from the clinical 
records as documented by the treating physician. Having 
‘any’ long-term endocrine disorder was defined as the pres-
ence of CDI, growth hormone (GH)-deficiency (GHD), 
hypothyroidism, hypogonadism, adrenocorticotropic hor-
mone (ACTH)-deficiency or obesity at last follow-up. GHD, 
hypothyroidism, hypogonadism and ACTH-deficiency were 
scored based on the written information of the treating phy-
sician in the medical chart. Panhypopituitarism was defined 
as a generalized deficit of all of the anterior pituitary hor-
mones. Body mass index (BMI) was calculated based on 
height and weight documented in the growth chart at last 
follow-up. Patients with a BMI at or above the 95th percen-
tile were regarded as obese [11].
Statistical analysis
The SPSS (version 22.0) statistical package was used for 
analysis. Multivariable logistic regression analysis was 
performed to identify risk factors by testing associations of 
clinical characteristics with severe (≥ 10 mmol/L/24 h) fluc-
tuations in the plasma sodium concentration level, adjusted 
for confounders. Likewise, logistic regression analysis was 
used to test associations of electrolyte disturbances and other 
clinical characteristics with short-term and long-term neuro-
logical consequences. All p values were based on two-sided 
testing and p values < 0.05 were considered as statistically 
significant.
Results
Baseline characteristics
The majority of the included patients had been diagnosed 
with craniopharyngioma (Table 1). Median age at initial sur-
gery was 8.5 years (range 0–18). Type of surgery was mainly 
partial resection (56.7%) and the transcranial approach was 
used more often than the transsphenoidal approach (82.5 
vs. 17.5%). Children under 7 years of age were all operated 
using the transcranial approach, while the transsphenoidal 
approach was used more frequent in adolescents. Thirty-
five patients (29.2%) underwent one or more resections 
after primary tumor surgery because of tumor recurrence or 
tumor progression. Adjuvant treatment with radiotherapy 
or chemotherapy was given in 48.3 and 24.2% of patients, 
respectively. Fifteen patients (12.5%) underwent both radi-
otherapy and chemotherapy. In nine patients (7.5%), CDI 
was already present at the time of tumor diagnosis (pre-
operative DI). Six patients (5.0%) had been treated with 
desmopressin before initial tumor surgery, while 82 (68.3%) 
patients received treatment with desmopressin in the direct 
postoperative period. Dosage of desmopressin could not be 
retrieved retrospectively. Median length of stay at the ICU 
was 2.0 days (range 1–18). Important postoperative compli-
cations probably occurring independent of fluctuations in 
plasma sodium concentration were meningitis (n = 4), sep-
ticemia (n = 2), pneumonia (n = 1), cellulitis (n = 1), urinary 
tract infection (n = 3), fever of unknown origin treated with 
antibiotics (n = 4), postoperative anemia requiring (multiple) 
blood transfusion(s) (n = 2) and hyperglycaemia requiring 
insulin therapy (n = 2). Median duration of follow-up was 
5.0 years (range 0.1–10). Mortality during follow-up was 
5.0% (n = 6): five patients died from tumor progression and 
one patient had a rapidly progressive neurological condition 
that was not related to the original tumor.
Frequency of postoperative fluctuations in plasma 
sodium concentration
Early postoperative CDI occurred in 81 patients (67.5%). 
Seven patients (5.8%) with early postoperative CDI did 
not have permanent CDI at last moment of follow-up. The 
postoperative triphasic response was observed in 27 of 81 
patients (22.5%). Among these patients, the median onset of 
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the first phase (polyuric) was at day 1 postoperative (range 
1–2), median onset of the second phase with oliguria was 
at day 4 (range 2–8) and median onset of the true CDI/third 
phase with polyuria was at day 9 (range 4–12). All patients 
with a postoperative triphasic response had permanent CDI 
at last follow-up. The triphasic response was also recognized 
in two out of the nine patients known with initial pre-opera-
tive CDI. It was noted that some patients who were already 
treated with desmopressin before tumor surgery tended to 
have a temporary reduced need for desmopressin in the post-
operative period.
Severity of fluctuations in plasma sodium 
concentration
Severe fluctuations of plasma sodium concentration were 
observed in the 81 patients with early postoperative CDI, 
ranging from 110 to 183 mmol/L (Fig. 1a, b). The highest 
plasma sodium concentrations occurred on the first postop-
erative day. In 1.9% of all measurements in patients with 
early postoperative CDI, plasma sodium concentrations over 
160 mmol/L were found. The lowest plasma sodium con-
centrations occurred on day 6 until day 8 postoperative. In 
1.8% of all measurements in patients with early postopera-
tive CDI, plasma sodium concentrations under 125 mmol/L 
were found. The maximum delta plasma sodium concentra-
tion (defined as the difference between highest and lowest 
plasma sodium concentration) per day during the first ten 
postoperative days was 46 mmol/L/day in a patient on the 
first postoperative day. In 75.3% of patients, fluctuations of 
plasma sodium concentration ≥ 10 mmol/L/day during the 
first ten postoperative days were seen, with a median number 
of two fluctuations ≥ 10 mmol/L/24 h per patient.
Neurological consequences of fluctuations 
in plasma sodium concentration
Short-term neurological consequences were observed sig-
nificantly more frequent in patients with early postopera-
tive CDI compared to patients without early postoperative 
CDI (32.1 vs. 10.3%, p = 0.007, OR 0.01, 95% CI 0.01–0.02) 
(Table 2). Altered mental status occurred more often in 
patients with early postoperative CDI compared to patients 
without early postoperative CDI (23.5 vs. 5.1%, p = 0.009, 
OR 0.01, 95% CI 0.01–0.01). At last follow-up, fatigue was 
observed more frequent in children with early postoperative 
CDI compared to children without early postoperative CDI 
(44.4 vs. 23.1%, p = 0.016, OR 0.02, 95% CI 0.02–0.03). 
Overall lowest plasma sodium concentration was related 
to the occurrence of short-term neurological consequences 
[both epileptic seizures and altered mental status, p values 
of respectively 0.003 (OR 0.77, 95% CI 0.64–0.92) and 
0.012 (OR 0.88, 95% CI 0.80–0.97)] (Table 3). All patients 
(100.0%) with epileptic seizures and 94.7% of patients with 
an altered mental status experienced fluctuations in plasma 
sodium concentration ≥ 10 mmol/L/24 h during the first ten 
postoperative days. No relation was found between changes 
Table 1  Baseline clinical characteristics of the study population
Values are presented as number (%) or median (range)
Y yes, N no
a Adenoma or prolactinoma or Rathke’s cleft cyst
b Central neurocytoma or rhabdomyosarcoma or hamartoma
c Missing data: 3 (2.5)
d Missing data: 1 (0.8)
e Missing data: 2 (1.7)
f Missing data: 36 (30.0)
Patients n (%)
Total 120 (100.0)
Gender
 Female 70 (58.3)
Pathology report: type of tumor
 Craniopharyngioma or xanthogranuloma 70 (58.3)
 Chiasmatic hypothalamic glioma (CHG) 29 (24.2)
 Germ cell tumor (GCT) 9 (7.5)
 Pituitary  tumora 9 (7.5)
 Other  tumorb 3 (2.5)
Median age at initial surgery (years) 8.5 (0–18)
Type of initial surgery
 Gross total resection (GTR) 36 (30.0)
 Partial resection 68 (56.7)
 Biopsyc 13 (10.8)
Surgical approach
 Transcranial 99 (82.5)
 Transsphenoidal 21 (17.5)
Total number of resections per patient
 n = 1 85 (70.8)
 n = 2 32 (26.7)
 n = 3 3 (2.5)
Radiotherapy y/n 58 (48.3)/62 (51.7)
 Craniopharyngioma or xanthogranuloma 34 (28.3)
 Chiasmatic hypothalamic glioma (CHG) 12 (10.0)
 Germ cell tumor (GCT) 7 (5.8)
 Pituitary  tumora 4 (3.3)
 Other  tumorb 1 (0.8)
Chemotherapy y/nd 29 (24.2)/90 (75.0)
Pre-operative diabetes insipidus y/ne 9 (7.5)/109 (90.8)
Early postoperative diabetes insipidus y/n 81 (67.5)/39 (32.5)
Permanent diabetes insipidus at last moment of 
follow-up y/ne
80 (66.7)/38 (31.7)
ICU length of stay (days)f 2.0 (1–18)
Median duration of follow-up (years) 5.0 (0–10)
Mortality during follow-up 6 (5)
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in the postoperative plasma sodi um concentration and long-
term neurological consequences (Table 4).
Risk factors for postoperative CDI
Multivariate logistic regression analysis revealed no signifi-
cant risk factors, in addition to the surgical intervention for 
the suprasellar tumor, for the occurrence of early postopera-
tive CDI. Permanent CDI at last moment of follow-up was 
present in 68% of patients. Seven patients (5.8%) without 
early postoperative CDI finally did present with permanent 
CDI. Risk factors for developing permanent CDI were early 
postoperative DI (p = 0.001, OR 0.01, 95% CI 0.00–0.11) 
and postoperative complications probably occurring inde-
pendent of fluctuations in plasma sodium concentration 
complications (p = 0.026, OR 0.06, 95% CI 0.01–0.71). 
Patients with permanent CDI at last follow-up experienced 
significantly more fluctuations in plasma sodium concentra-
tion ≥ 10 mmol/L/24 h during the first 10 postoperative days 
than patients with transient CDI and patients without CDI 
(p = 0.007, OR 26.89, 95% CI 2.43–297.31) (Table 5). No 
statistically significant differences were found between the 
various academic medical centers regarding the number of 
changes in serum sodium concentration > 10 mmol/L within 
24 h during the first 10 days postoperative or neurological 
outcome of the patients.
Discussion
In our large retrospective national cohort study of children 
operated on sellar or suprasellar tumors and treated in aca-
demic centers, a high frequency of CDI was found. The 
number of clinically relevant fluctuations in plasma sodium 
concentration was considerable, with plasma sodium levels 
ranging from 110 to 183 mmol/L and a maximum delta of 
46 mmol/L/24 h. These findings illustrate the difficulty in 
management of postoperative CDI in children, which may 
Fig. 1  a Median highest and 
median lowest plasma sodium 
concentration per day (including 
upper and lower range) during 
the first 10 days after tumor 
surgery in the 81 patients with 
early postoperative DI. b Delta 
plasma sodium concentration 
per day (including median, 
upper and lower range) during 
the first 10 days after tumor 
surgery in the 81 patients with 
early postoperative DI
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partly be due to the low incidence of tumors in the sellar 
or suprasellar region in children in combination with the 
occurrence of the unpredictable triphasic response. The 
results of this study emphasize the need for highly expe-
rienced centers taking care of these patients, which was 
also previously concluded by Edate and Albanese [12]. 
They suggested that these patients should be referred to 
specialist centers and managed by designated multidis-
ciplinary teams involving a neuroradiologist, pediatric 
neurosurgeon, pediatric oncologist and pediatric endocri-
nologist with access to appropriate specialist pathology 
and pediatric intensive care facilities. The incidence of 
postoperative CDI (68%) in our study was high compared 
to the incidence of 10–63% as described in literature [4–6, 
13], possibly explained by the inclusion criteria of our 
cohort. Radical excision of craniopharygioma, recurrent 
tumor surgery and transcranial approach have been identi-
fied as predictors for early postoperative CDI in children 
[13–21]. In our study, none of these factors predicted early 
postoperative CDI. The triphasic response was observed in 
23% (n = 27) of patients, with a median day of onset of the 
first phase on day 1. Remarkably, some patients who had 
Table 2  Short-term (≤ 10 postoperative days) and long-term neurological consequences in all patients and in patients with or without early post-
operative DI
Values are presented as number (%)
All patients
n (%)
Missing
n (%)
Occurrence of early postopera-
tive DI (≤ 10 days)
p value OR (95% CI)
Yes
n (%)
No
n (%)
Patients 120 – 81 39 – –
Short-term neurological consequences 30 (25.0) 3 (2.5) 26 (32.1) 4 (10.3) 0.007 0.01 (0.01–0.02)
 Epileptic seizure(s) 15 (12.5) 2 (1.7) 13 (16.0) 2 (5.1) 0.084 0.15 (0.14–0.15)
 Altered mental status 21 (17.5) 5 (4.2) 19 (23.5) 2 (5.1) 0.009 0.01 (0.01–0.01)
Long-term neurological consequences 104 (86.7) 3 (2.5) 70 (86.4) 34 (87.2) 0.890 1.00 (1.00–1.00)
 Headache 31 (25.8) 7 (5.8) 20 (24.7) 11 (28.2) 0.800 0.82 (0.82–0.83)
 Epileptic seizure(s) 13 (10.8) 7 (5.8) 11 (13.6) 2 (5.1) 0.141 0.21 (0.20–0.22)
 Visual impairment 77 (64.2) 6 (5.0) 51 (63.0) 26 (66.7) 0.889 1.00 (1.00–1.00)
 Motor deficit 30 (25.0) 5 (4.2) 22 (27.2) 8 (20.5) 0.392 0.50 (0.49–0.51)
 Cognitive dysfunction 39 (32.5) 11 (9.2) 30 (37.0) 9 (23.1) 0.075 0.09 (0.09–0.10)
 Sleeping problems 18 (15.0) 9 (7.5) 11 (13.6) 7 (17.9) 0.589 0.79 (0.78–0.80)
 Fatigue 45 (37.5) 8 (6.7) 36 (44.4) 9 (23.1) 0.016 0.02 (0.02–0.03)
Table 3  Multivariate analysis for risk factors to develop short-term neurological consequences in patients with early postoperative DI (n = 81)
Values are presented as number (%) or median (range)
Epileptic seizure(s) Altered mental status
Yes
n (%)
p value OR (95% CI) Yes
n (%)
p value OR (95% CI)
Patients (n = 81) 13 – – 19 – –
Delta plasma sodium concentra-
tion ≥ 10 mmol/L/24 h
13 (100.0) 0.998 1.36 × 108 (0.00–) 18 (94.7) 0.410 2.67 (0.26–2.76 × 101)
Overall highest plasma sodium concentration 
(mmol/L)
151 (140–179) 0.399 0.95 (0.85–1.07) 152 (144–183) 0.050 1.08 (1.00–1.17)
Overall lowest plasma sodium concentration 
(mmol/L)
121 (110–134) 0.003 0.77 (0.64–0.92) 126 (110–144) 0.012 0.88 (0.80–0.97)
Age at initial surgery (years) 5.0 (0–14) 0.129 0.84 (0.67–1.05) 10.0 (1–18) 0.162 1.12 (0.96–1.30)
Preoperative epileptic seizure(s) 2 (15.4) 0.030 0.04 (0.00–0.72) 2 (10.5) 0.170 0.13 (0.01–2.38)
Surgical approach: transcranial 12 (92.3) 0.394 4.12 (0.16–1.07 × 102) 18 (94.7) 0.182 0.17 (0.01–2.31)
Postoperative complications probably occur-
ring independent of fluctuations in plasma 
sodium concentration
8 (61.5) 0.167 0.24 (0.03–1.82) 10 (52.6) 0.568 0.69 (0.19–2.47)
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already been diagnosed with pre-operative CDI also expe-
rienced a triphasic response after surgery, without need for 
desmopressin in the phase of SIADH. In these patients, the 
hyponatriemic phase was most probably caused by over-
treatment with desmopressin, excessive fluids and/or per-
haps intercurrent cerebral salt wasting [22]. Our data con-
firm previous findings that all patients with the triphasic 
response in the postoperative period develop permanent 
CDI [7]. The patients with permanent CDI showed the 
most severe fluctuations in plasma sodium concentration 
during the early postoperative period. This finding sug-
gests that patients with difficulties in management of dia-
betes insipidus in the early postoperative period are more 
likely to develop permanent CDI. It was remarkable that 
all patients with early postoperative CDI were at risk of 
short-term (altered mental status) and long-term (fatigue) 
neurological consequences. Especially the steep decline in 
plasma sodium concentration during the early postopera-
tive course, resulting in hyponatremia, was associated with 
immediate neurological consequences (epileptic seizures 
and altered mental status). Our results expand on previous 
findings by Williams et al. [8], who studied the incidence 
of postoperative hyponatremia and associated neurologi-
cal consequences in children with a brain tumor. In their 
retrospective cohort study of 319 children, hyponatremia 
occurred in 39 children (12%) and was frequently symp-
tomatic: 21% had seizures and 41% had altered mental 
status. Also, in this study hyponatremia was associated 
with more complicated hospital courses (mechanical ven-
tilation, supplemental nutrition), infection and moderate 
or worse disability by Pediatric Cerebral Performance 
Category score at discharge. Bohl et al. [23] identified 
delayed hyponatremia (SIADH) and DI as the most com-
mon causes of 30-day unplanned readmission after trans-
sphenoidal surgery for pituitary tumors.
Table 4  Multivariate analysis for risk factors to develop long-term neurological consequences in patients with early postoperative DI (n = 81)
Values are presented as number (%) or median (range). Long term is defined as measured at last follow-up
Cognitive dysfunction Fatigue
Yes
n (%)
p value OR (95% CI) Yes
n (%)
p value OR (95% CI)
Patients (n = 81) 30 – – 36 – –
Delta plasma sodium concentra-
tion ≥ 10 mmol/L/24 h
27 (90.0) 0.074 5.07 (0.85–30.05) 29 (80.6) 0.439 1.68 (0.45–6.22)
Overall highest plasma sodium concentration 
(mmol/L)
152 (140–183) 0.201 1.05 (0.97–1.13) 152 (143–183) 0.842 0.99 (0.93–1.06)
Overall lowest plasma sodium concentration 
(mmol/L)
131.5 (110–145) 0.445 0.97 (0.89–1.06) 132 (110–145) 0.942 1.00 (0.93–1.08)
Total number of resections per patient 1 (1–3) 0.494 1.45 (0.50–4.22) 1 (1–3) 0.758 0.86 (0.33–2.25)
Radiotherapy 22 (73.3) 0.064 0.32 (0.10–1.07) 23 (63.9) 0.106 0.42 (0.15–1.20)
Postoperative complications probably occurring 
independent of fluctuations in plasma sodium 
concentration
13 (43.3) 0.711 0.80 (0.24–2.65) 16 (44.4) 0.362 0.62 (0.23–1.72)
Panhypopituitarism at last follow-up 17 (56.7) 0.029 4.68 (1.17–18.79) 27 (75.0) 0.426 0.63 (0.20–1.98)
Table 5  Multivariate analysis: 
pre- and post-operative patient 
characteristics related to fluctua-
tions in plasma sodium con-
centration ≥ 10 mmol/L/24 h. 
during the first ten postoperative 
days (n = 120)
ICU intensive care unit, OR odds ratio, 95% CI 95% confidence interval
p value OR (95% CI)
Gender 0.822 1.16 (0.31–4.37)
DI at diagnosis 0.564 1.78 (0.25–12.47)
Age at initial surgery (years) 0.300 0.92 (0.79–1.07)
ICU length of stay (days) 0.316 1.14 (0.88–1.48)
Postoperative complications probably occurring independent of 
fluctuations in plasma sodium concentration
0.698 1.28 (0.36–4.52)
Transient DI during the first ten postoperative days 0.324 5.17 (0.20–135.43)
Permanent DI 0.007 26.89 (2.43–297.31)
Panhypopituitarism at last follow-up 0.837 1.17 (0.27–5.13)
Obesity at last follow-up 0.213 2.36 (0.61–9.08)
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Strengths and limitations
The strength of this study is the relatively large sample 
size from a well-described national cohort. We were able 
to study a 10 day-postoperative period, including metic-
ulous follow-up of the plasma sodium concentration. 
Our study also has several limitations, which have to be 
acknowledged. A prospective cohort study with standard-
ized data collection would be more optimal to study the 
short-term and long-term effects of CDI, compared to the 
current retrospective design. Additionally, more detailed 
information could then be collected about fluid and desmo-
pressin administration. The results of our study need to be 
regarded in this context. Due to the retrospective design, 
there were some missing data concerning pre-operative, 
perioperative (e.g. fluid balance) and postoperative man-
agement (e.g. dosage of dexamethasone administration, 
sodium supplementation in patients with hyponatremia, 
in some cases exact fluid balance). In 6 of the 81 patients 
with DI, the diagnosis of DI was based on documenta-
tion from the treating physician in the medical chart. In 
these patients, the diagnosis of DI had been made in the 
very first hours after surgery, while no retrospective data 
were available on plasma sodium concentrations directly 
perioperative. Furthermore, no information regarding 
urine specific gravity was collected. Urine specific grav-
ity can be useful for the diagnosis of diabetes insipidus: 
polyuria with an increase in plasma osmolarity and urine 
osmolality dropping to below 300 mOsm/kg is suggestive 
for the presence of DI [24]. For these reasons, our results 
should be interpreted with care before causal interpreta-
tions are made. Larger prospective studies are needed to 
elucidate these possible relations, along with the ques-
tion as to whether the severity of fluctuations in plasma 
sodium concentration and neurological consequences can 
be reduced by further centralization of care.
Conclusion
Early postoperative CDI is frequently seen in children oper-
ated on a sellar or suprasellar tumor. Patients with early 
postoperative CDI and steep decline in plasma sodium con-
centration are at risk to develop an altered mental status and 
seizures in the first 10 days postoperative. Despite current 
high-level care, many outliers and fluctuations of plasma 
sodium concentration are still being observed in the postop-
erative period. Therefore, patients requiring surgery in the 
sellar or suprasellar region should be monitored in a highly 
experienced center. Possible improvement of outcome could 
be strived for by using multidisciplinary protocolized care 
for maintaining an adequate sodium and water balance.
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